HI
REGN icon

HBK Investments’s Regeneron Pharmaceuticals REGN Stock Holding History

HBK Investments’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-12,870
Closed -$4.83M – 425
2019
Q4 		$4.83M Buy
+12,870
New +$4.33M 0.05% 280
2019
Q2 		– Sell
-17,449
Closed -$7.17M – 957
2019
Q1 		$7.17M Buy
+17,449
New +$7.19M 0.07% 236
2018
Q1 		– Sell
-36,800
Closed -$13.8M – 1114
2017
Q4 		$13.8M Buy
36,800
+33,357
+969% +$13.5M 0.11% 118
2017
Q3 		$1.54M Buy
+3,443
New +$1.64M 0.01% 510
2016
Q1 		– Sell
-15,600
Closed -$8.47M – 1091
2015
Q4 		$8.47M Buy
15,600
+7,200
+86% +$3.9M 0.08% 145
2015
Q3 		$3.91M Buy
+8,400
New +$4.51M 0.04% 282
2015
Q2 		– Sell
-6,900
Closed -$3.12M – 1069
2015
Q1 		$3.12M Sell
6,900
-14,925
-68% -$6.33M 0.03% 325
2014
Q4 		$8.95M Sell
21,825
-830
-4% -$326K 0.11% 136
2014
Q3 		$8.17M Sell
22,655
-8,040
-26% -$2.69M 0.13% 130
2014
Q2 		$8.67M Sell
30,695
-7,005
-19% -$2.08M 0.18% 107
2014
Q1 		$11.3M Sell
37,700
-38,200
-50% -$11.8M 0.21% 82
2013
Q4 		$20.9M Buy
75,900
+17,089
+29% +$4.92M 0.4% 34
2013
Q3 		$18.4M Sell
58,811
-33,289
-36% -$8.76M 0.27% 50
2013
Q2 		$20.7M Buy
+92,100
New +$21.4M 0.32% 41

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

HBK Investments's REGN Position: Q1 2020 in Review

HBK Investments sold out of Regeneron Pharmaceuticals (REGN) in Q1 2020, closing a stake of 12,870 shares — an estimated $4.83M sold.

HBK Investments first reported a position in REGN in Q2 2013 and held it in 14 quarters. The position peaked at $20.9M in Q4 2013. 816 funds tracked by Wall St. Rank hold REGN as of Q1 2020.

  • HBK Investments reported no remaining Regeneron Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • HBK Investments sold 12,870 Regeneron Pharmaceuticals shares in Q1 2020, an estimated $4.83M.
  • HBK Investments first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 14 quarters.
  • HBK Investments's Regeneron Pharmaceuticals position peaked at $20.9M in Q4 2013.
  • 816 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2020.

Based on HBK Investments's 13F filing for Q1 2020, filed 15 May 2020.